
A consistent approach to selecting and dosing immunomodulatory medications where indicated.

Guidance on timing relative to the treatment cycle, including spontaneous conception and natural frozen embryo transfer (NAT-FET).

Structured monitoring and record-keeping throughout assessment and treatment.

Assessment of HLA-DQ alpha gene compatibility between partners as part of the workup.

Specialist immune testing, including interpretation of results to support clinical decisions.

A streamlined referral route to specialist testing for network clinicians.

Online units covering Dr Lolatgis' protocols, diagnostic approach and treatment algorithms.

Receive personalised guidance throughout your onboarding and early cases, with ongoing support through four live group webinars each year and access to the network’s Clinical Advisor for the review of medication protocols in complex cases.

Access to the coordinating team for complex case discussion and second opinions.

Protocols, resources and decision-support tools as the framework evolves.

Day-to-day support for patient workflow, treatment-plan actioning and protocol questions.

Access specialist immune testing, including result interpretation to support clinical decision-making. LMIT treatment access is available exclusively through The Fertility Network.

Documentation, consent forms and clinical governance structure provided.

Connect with other participating clinicians for shared learning and collaboration.




